L, A., E, O., M, S., E, B., F, P., S, B., . . . M, L. (2004). Combination of rituximab, cyclophosphamide, and vincristine induces complete hematologic remission of splenic marginal zone lymphoma. Clinical lymphoma, 4(4), 250. https://doi.org/10.3816/clm.2004.n.005
Chicago Style (17th ed.) CitationL, Arcaini, et al. "Combination of Rituximab, Cyclophosphamide, and Vincristine Induces Complete Hematologic Remission of Splenic Marginal Zone Lymphoma." Clinical Lymphoma 4, no. 4 (2004): 250. https://doi.org/10.3816/clm.2004.n.005.
MLA (9th ed.) CitationL, Arcaini, et al. "Combination of Rituximab, Cyclophosphamide, and Vincristine Induces Complete Hematologic Remission of Splenic Marginal Zone Lymphoma." Clinical Lymphoma, vol. 4, no. 4, 2004, p. 250, https://doi.org/10.3816/clm.2004.n.005.